And dose optimization, sometimes going up, sometimes going down, can reignite progress
Outfits start to fit a little differently, and self-confidence takes a hit
Rosenstock et al., 2019) investigating the safety and efficacy of incretin-based drugs have provided diverse interpretations and provocative intellectual curiosities regarding the biology of incretin hormones and incretin-based drugs, specifically focusing on pleiotropic effects
190 More specifically, in cirrhosis patients, a denser, more uniform bacterialarchaealviral network centered on Ruminococcaceae and Christensenellaceae at baseline is associated with the risk of future decompensation events
Tirzepatide is a new molecule with patent protection expected into the late 2030s (at least 2034+)